CompletedPhase 2

Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)

United States182 participantsStarted 2016-10-01

Plain-language summary

This is a randomized controlled Phase II clinical trial designed to evaluate the effects of N-acetylcysteine (NAC) in reducing Alcohol Use Disorder (AUD) severity and Post Traumatic Stress Disorder (PTSD) symptomatology among individuals with current AUD and PTSD.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Male or female; any race or ethnicity; age 18 to 70 years old.
. Subjects must be able to comprehend English.
. Meet DSM-5 criteria for current alcohol use disorder (AUD).

Exclusion criteria

. Subjects taking psychotropic medications will be required to be maintained on a stable dose for at least four weeks before treatment initiation. This is because initiation or change of medications during the course of the trial may interfere with interpretation of results.
. Must consent to random assignment to N-acetylcysteine (NAC) or placebo.
. Must consent to complete all treatment and follow-up visits.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Alcohol Use Severity

Timeframe: From baseline to week 12

Change in Alcohol Craving - Obsessive Subscale

Timeframe: From baseline to week 12

Change in Post Traumatic Stress Disorder Symptom Severity - Clinician Rated

Timeframe: From baseline to week 12

Change in Post Traumatic Stress Disorder Symptom Severity - Self Report

Timeframe: From baseline to week 12

Change in Alcohol Craving - Compulsive Subscale

Timeframe: From baseline to week 12

Change in Alcohol Use Severity - Percent Days Abstinent

Timeframe: From baseline to week 12

Trial details

NCT IDNCT02966873

SponsorMedical University of South Carolina

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09-16

Results submitted2022-12-22

View on ClinicalTrials.gov More Post Traumatic Stress Disorder (PTSD) trials

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Male or female; any race or ethnicity; age 18 to 70 years old.
. Subjects must be able to comprehend English.
. Meet DSM-5 criteria for current alcohol use disorder (AUD).

Exclusion criteria

. Subjects taking psychotropic medications will be required to be maintained on a stable dose for at least four weeks before treatment initiation. This is because initiation or change of medications during the course of the trial may interfere with interpretation of results.
. Must consent to random assignment to N-acetylcysteine (NAC) or placebo.
. Must consent to complete all treatment and follow-up visits.

What they're measuring

Change in Alcohol Use Severity

Timeframe: From baseline to week 12

Change in Alcohol Craving - Obsessive Subscale

Timeframe: From baseline to week 12

Change in Post Traumatic Stress Disorder Symptom Severity - Clinician Rated

Timeframe: From baseline to week 12

Change in Post Traumatic Stress Disorder Symptom Severity - Self Report

Timeframe: From baseline to week 12

Change in Alcohol Craving - Compulsive Subscale

Timeframe: From baseline to week 12

Change in Alcohol Use Severity - Percent Days Abstinent

Timeframe: From baseline to week 12